Understanding Technetium from Nuclear Fission — The First Artificially Made Element

Carlo Perrier and Emilio Segrè created technetium in 1937 by bombarding molybdenum with deuterons in the Berkeley cyclotron — making it the first element produced artificially. Dmitri Mendeleev had predicted its existence in 1871 as 'eka-manganese' (element 43), and decades of false discovery claims followed. The name technetium comes from the Greek 'technetos' (artificial). It was the lightest element with no stable isotopes, filling the last gap in the periodic table below element 93.

Technetium is remarkable for being the lightest element with no stable isotopes — every isotope is radioactive. Nuclear physics explains this through the Mattauch isobar rule: stable isobars of neighboring elements (molybdenum-98 and ruthenium-98) prevent technetium isotopes at those mass numbers from being stable. The longest-lived isotope, Tc-98, has a half-life of 4.2 million years — long on human timescales but short relative to the age of the Solar System.

Paul Merrill detected technetium spectral lines in red giant stars in 1952 — a transformative discovery. Since Tc-98's half-life is only 4.2 million years and these stars are billions of years old, the technetium must be freshly synthesized inside the star by slow neutron capture (the s-process). This was the first direct observational proof that nuclear fusion creates heavy elements in stellar interiors, confirming the theory of stellar nucleosynthesis.

Virtually all technetium used in medicine comes from the decay of molybdenum-99, which is produced by neutron irradiation of uranium-235 targets in nuclear research reactors. Mo-99 (half-life 66 hours) decays to Tc-99m (half-life 6 hours) by beta emission. A technetium generator ('moly cow') contains Mo-99 adsorbed on an alumina column — hospitals elute fresh Tc-99m daily by passing saline through the column. Global demand requires continuous reactor production.

Technetium-99m is the most widely used medical radioisotope in the world, involved in over 40 million diagnostic procedures annually. Its 6-hour half-life is long enough for imaging but short enough to minimize patient radiation. Tc-99m emits a single 140 keV gamma ray — ideal energy for gamma camera detection. It images the heart (myocardial perfusion), bones (metastatic cancer), kidneys, thyroid, lungs, and brain. No other isotope matches its combination of properties.

Tc-99m's versatility comes from technetium's rich coordination chemistry. In the +7 oxidation state, pertechnetate (TcO₄⁻) targets the thyroid and stomach. Reduced technetium binds to phosphonate ligands for bone scans, DTPA for kidney imaging, and sestamibi for cardiac perfusion studies. Technetium can adopt oxidation states from -1 to +7 and form complexes with virtually any biological targeting molecule, making it the most adaptable element in nuclear medicine.

The global Mo-99/Tc-99m supply depends on just six aging nuclear research reactors — the NRU in Canada (shut down 2018), HFR in Netherlands, BR2 in Belgium, SAFARI-1 in South Africa, OPAL in Australia, and Maria in Poland. Reactor shutdowns in 2009-2010 caused a worldwide medical isotope crisis. New production methods including cyclotron production and neutron activation of Mo-98 are being developed to reduce dependence on highly enriched uranium targets.

Technetium pertechnetate (TcO₄⁻) is an extraordinarily effective corrosion inhibitor for steel — concentrations as low as 5 ppm completely prevent rusting in aerated water. The pertechnetate ion creates a passive oxide layer on the iron surface. However, technetium's radioactivity makes this application impractical for general use. The corrosion-inhibiting properties were studied extensively for potential use in nuclear reactor cooling systems where technetium is already present as a fission product.

Technetium-99 (half-life 211,000 years) is a major long-lived fission product in spent nuclear fuel. Each ton of spent fuel contains approximately 1 kg of Tc-99. As pertechnetate, it is highly mobile in groundwater and difficult to immobilize in geological repositories. Transmutation — converting Tc-99 to stable Ru-100 by neutron capture — is being researched as a way to eliminate this waste. Vitrification in borosilicate glass is the current disposal method.

Record technetium's key data: atomic number 43, density 11.5 g/cm³, melting point 2,157°C, silvery-gray metal. Technetium is the element that proved Mendeleev right, confirmed stellar nucleosynthesis, and became indispensable to modern medicine. Despite having no stable form on Earth, Tc-99m saves more lives through diagnostic imaging than any other radioisotope. From a gap in the periodic table to 40 million medical scans per year — technetium's story is one of science turning the artificial into the essential.